Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Direxion Daily S&P 500 Bear 3X Shares ETF
SPXS
5
ProShares UltraPro Short S&P500 ETF
SPXU
US Stock MarketDetailed Quotes
GBIO Generation Bio
- 0.4359
- -0.0041-0.93%
Close May 2 16:00 ET
- 0.4359
- 0.00000.00%
Post 20:01 ET
29.21MMarket Cap-0.22P/E (TTM)
0.4540High0.4317Low219.31KVolume0.4470Open0.4400Pre Close96.38KTurnover0.45%Turnover RatioLossP/E (Static)67.01MShares4.340052wk High0.34P/B21.42MFloat Cap0.316052wk Low--Dividend TTM49.15MShs Float55.7200Historical High--Div YieldTTM5.07%Amplitude0.3160Historical Low0.4390Avg Price1Lot Size
About Generation Bio Company
Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.
Company Profile
SymbolGBIO
Company NameGeneration Bio
Listing DateJun 12, 2020
Issue Price19.00
Founded2016
CEODr. Geoffrey McDonough, M.D.
MarketNASDAQ
Employees115
Fiscal Year Ends12-31
Address301 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-655-7500
Websitehttp://www.generationbio.com
Company Executives
- Name
- Position
- Salary
- Dr. Geoffrey McDonough, M.D.
- President, Chief Executive Officer and Director
- 1.81M
- Kevin Conway
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Phillip Samayoa, PhD
- Chief Scientific Officer
- 931.76K
- Yalonda Howze, J.D.
- Chief Legal Officer and Corporate Secretary
- --
- Antionette Paone, M.B.A.,M.S.
- Chief Operating Officer
- 931.96K
- Jason P. Rhodes
- Chairman of the Board
- 251.48K
- Dannielle Appelhans
- Independent Director
- 210.48K
- Ronald H.W. Cooper
- Independent Director
- 214.48K
- Gustav A. Christensen
- Independent Director
- 213.98K
- Charles A. Rowland, Jr,M.B.A.
- Independent Director
- 221.48K
- Anthony G. Quinn, Ch.B.,M.B.,PhD
- Independent Director
- 213.98K
- Dr. Jeffrey M. Jonas,M.D.
- Independent Director
- 210.48K
- Dr. Donald W. Nicholson, PhD
- Independent Director
- 213.98K
- Dr. Catherine Stehman-Breen, M.D.
- Independent Director
- 213.98K
Market Insights
Discussing
BRK cash at new high: What to expect from Buffett’s meeting?
🎙️Discussion 1. Buffett said he won't sell Japanese stocks for the next ten years. What's your take? 2. In the face of market changes, do y
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
